CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 93 filers reported holding CYTOSORBENTS CORP in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $53,000 | -24.3% | 16,730 | 0.0% | 0.00% | – |
| Q4 2021 | $70,000 | -50.0% | 16,730 | -2.9% | 0.00% | – |
| Q3 2021 | $140,000 | +7.7% | 17,229 | 0.0% | 0.00% | – |
| Q2 2021 | $130,000 | -20.2% | 17,229 | -8.3% | 0.00% | – |
| Q1 2021 | $163,000 | +15.6% | 18,791 | +6.3% | 0.00% | – |
| Q4 2020 | $141,000 | +38.2% | 17,679 | +38.1% | 0.00% | – |
| Q3 2020 | $102,000 | -12.1% | 12,803 | +9.3% | 0.00% | – |
| Q2 2020 | $116,000 | -11.5% | 11,711 | -31.0% | 0.00% | – |
| Q1 2020 | $131,000 | +70.1% | 16,979 | -14.8% | 0.00% | – |
| Q4 2019 | $77,000 | +4.1% | 19,921 | +35.6% | 0.00% | – |
| Q3 2019 | $74,000 | -23.7% | 14,693 | 0.0% | 0.00% | – |
| Q2 2019 | $97,000 | +2.1% | 14,693 | +16.9% | 0.00% | – |
| Q1 2019 | $95,000 | -6.9% | 12,570 | 0.0% | 0.00% | – |
| Q4 2018 | $102,000 | -26.6% | 12,570 | +16.8% | 0.00% | – |
| Q3 2018 | $139,000 | – | 10,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 692,738 | $5,524,000 | 2.01% |
| Skylands Capital, LLC | 1,421,700 | $11,345,000 | 1.89% |
| SECTORAL ASSET MANAGEMENT INC | 1,629,989 | $12,999,000 | 1.12% |
| Winning Points Advisors, LLC | 286,200 | $1,142,990,000 | 0.97% |
| Redmile Group, LLC | 2,101,131 | $16,757,000 | 0.31% |
| Granahan Investment Management | 632,035 | $5,040,000 | 0.17% |
| Avenir Corp | 190,240 | $1,517,000 | 0.16% |
| Seelaus Asset Management LLC | 20,000 | $160,000 | 0.13% |
| Olympiad Research LP | 17,816 | $142,000 | 0.07% |
| HighMark Wealth Management LLC | 10,000 | $80,000 | 0.07% |